tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Dermata Therapeutics Ends License Agreement with Villani
PremiumCompany AnnouncementsDermata Therapeutics Ends License Agreement with Villani
2M ago
Dermata Therapeutics Shifts Focus to OTC Skincare
Premium
Company Announcements
Dermata Therapeutics Shifts Focus to OTC Skincare
2M ago
Dermata Therapeutics Increases Stock Offering by $1.79M
Premium
Company Announcements
Dermata Therapeutics Increases Stock Offering by $1.79M
2M ago
Dermata Therapeutics withdraws IND application for XYNGARI
PremiumThe FlyDermata Therapeutics withdraws IND application for XYNGARI
4M ago
Dermata Therapeutics Regains Nasdaq Compliance by August 2025
Premium
Company Announcements
Dermata Therapeutics Regains Nasdaq Compliance by August 2025
5M ago
Dermata Therapeutics price target lowered to $10 from $30 at Maxim
Premium
The Fly
Dermata Therapeutics price target lowered to $10 from $30 at Maxim
5M ago
Dermata Therapeutics receives notice of grant of Australian patent
PremiumThe FlyDermata Therapeutics receives notice of grant of Australian patent
6M ago
Dermata Faces Nasdaq Delisting Risk, Plans Stock Split
Premium
Company Announcements
Dermata Faces Nasdaq Delisting Risk, Plans Stock Split
6M ago
Dermata Therapeutics Begins Manufacturing for STAR-2 Trial
Premium
Company Announcements
Dermata Therapeutics Begins Manufacturing for STAR-2 Trial
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100